SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-040135
Filing Date
2015-05-07
Accepted
2015-05-07 17:58:47
Documents
1
Period of Report
2015-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7073
  Complete submission text file 0001209191-15-040135.txt   8681
Mailing Address C/O AEGERION PHARMACEUTICALS, INC. 89 HEADQUARTERS PLAZA, SUITE 1212 MORRISTOWN NJ 07960
Business Address
Carter Martha J. (Reporting) CIK: 0001213040 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 15843345

Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations